Translation and Skills Gap Program

The department has partnered with Brandon BioCatalyst, Australasia’s leading life science venture capital firm, to deliver a pilot Translation and Commercialisation Skills Gap program for Queensland-based biomed founders and businesses.

The program features two parts:

• A selected cohort of participants to attend practical workshops exploring business planning, CUREator grants, clinical and regulatory development, and BIO preparation and planning.
• A seminar series covering pivotal subjects like pre-commercialisation planning, early preclinical development, clinical and regulatory strategy, and company formation, investment, and partnering for Queensland founders

Queensland’s 2024 cohort

Twelve companies and entrepreneurs have been selected to be guided by Brandon BioCatalyst on a transformative journey that culminates in the opportunity to attend BIO2024 in San Diego (at your own expense).

Seminar series

Queenslanders in the biomedical industry wanting to upskill in translation and commercialisation, expansion and going global are encouraged to attend the seminar series. During the series, guest speakers with industry expertise will guide attendees to increase their knowledge and ability to appreciate the considerations, networks and pathways for successful therapeutics development.

Tuesday, 27 February 2024	Preparing your research for Translation Content covering therapeutic development planning, early commercialisation considerations and spin out creation.
Thursday, 21 March 2024	Translating research discoveries into drug development programs Content covering formal Preclinical Development requirements to support translation
Tuesday, 23 April 2024	Translating research to the Clinic Preparing for and completing clinical development activities, including regulatory aspects and designing and conducting clinical trials
Tuesday, 7 May 2024	Company formation, fundraising and partnering

All seminars will be delivered at the Translational Research Institute on the PA Hospital campus in Woolloongabba starting in February 2024.

Who should attend

Queensland-based biomed founders, researchers and entrepreneurial academics or early-stage businesses commercialising novel therapeutics that will positively impact people's health globally.

Register your attendance.